BioSpace News Archive

Suda Reveals New Data Supporting Use of Anagrelide to Treat Cancer

SUDA announces the presentation of new data at the ASH Annual Meeting that support the use of SUDA’s anagrelide for the treatment of solid tumours.

December 13, 2017

·

2 min read

Drug Development

Hovione Announces Enrollment of First Patient in MARS, a Phase II Clinical Trial for the Treatment of Moderate to Severe Inflammatory Rosacea With its Proprietary Minocycline Topical Gel

The primary endpoint will include a change in inflammatory lesions from baseline. MARS will include 23 investigational sites across the United States and will enroll 249 subjects. The study is expected to be completed by the end of 2018.

December 13, 2017

·

3 min read

Drug Development

Stemline Therapeutics Presents Detailed SL-401 Pivotal Data in BPDCN at ASH and Kicks Off its BPDCN Awareness Campaign; Updated Results From Ongoing Trials in Additional Malignancies Also Presented

Presentations are available on the Stemline website, www.stemline.com, under the Scientific Presentations tab.

December 13, 2017

·

7 min read

Ossur Hf : Financial Calendar 2018

A look at Ossur’s financial calendar for 2018.

December 13, 2017

·

1 min read

Deals

Denali Therapeutics Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Goldman Sachs & Co. LLC, Morgan Stanley and J.P. Morgan acted as joint book-running managers for the offering, and Evercore Group L.L.C. acted as lead manager for the offering.

December 13, 2017

·

1 min read

Pharm Country

Brainsway Raises $8.5M From Leading Israeli Investors

The financing was led by the Phoenix Group (Israel), which will own more than 7% in the Company.

December 13, 2017

·

3 min read

Eisai’s Aricept Approved for Additional Indication of Severe Alzheimer’s Disease in China

The approval of the additional indication was based on the results of a Phase III clinical study in China.

December 13, 2017

·

4 min read

Titan Medical Strengthens Patent Portfolio With Issuance of Two Canadian Patents and Allowance of a Japanese Patent

In addition to the issuance of the Canadian patents, the Company has received an official Decision to Grant from the Japan Patent Office regarding a pending Japanese patent application.

December 13, 2017

·

4 min read

Pharm Country

Shareholders of Epicore BioNetworks Overwhelmingly Approve Proposed Transaction With Neovia Probiotics a Wholly Owned Subsidiary of Neovia S.A.S.

The Arrangement is expected to be completed on December 18, 2017.

December 13, 2017

·

1 min read

Policy

FDA Accepts Bristol-Myers’ Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) in Intermediate- and Poor-Risk Patients With Advanced Renal Cell Carcinoma and Grants Priority Review

Bristol-Myers Squibb Company announced today that the FDA has accepted its supplemental Biologics License Application (sBLA) for priority review of Opdivo (nivolumab) plus Yervoy (ipilimumab) to treat intermediate- and poor-risk patients with advanced renal cell carcinoma (RCC).

December 13, 2017

·

28 min read